vijoice

Generic: alpelisib

Labeler: novartis pharmaceuticals corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name vijoice
Generic Name alpelisib
Labeler novartis pharmaceuticals corporation
Dosage Form GRANULE
Routes
ORAL
Active Ingredients

alpelisib 50 mg/1

Manufacturer
Novartis Pharmaceuticals Corporation

Identifiers & Regulatory

Product NDC 0078-1175
Product ID 0078-1175_6993f70f-a922-4520-9537-ec6cea3bd915
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA218466
Listing Expiration 2026-12-31
Marketing Start 2024-04-24

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00781175
Hyphenated Format 0078-1175

Supplemental Identifiers

RxCUI
2169310 2169316 2169319 2598459 2598461 2598463 2598464 2598465 2598466 2598467 2598469 2598470 2680135 2680138 2680139 2680140
UNII
08W5N2C97Q

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vijoice (source: ndc)
Generic Name alpelisib (source: ndc)
Application Number NDA218466 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 28 PACKET in 1 CARTON (0078-1175-51) / 1 GRANULE in 1 PACKET (0078-1175-19)
source: ndc

Packages (1)

0078-1175-51 28 PACKET in 1 CARTON (0078-1175-51) / 1 GRANULE in 1 PACKET (0078-1175-19)

Ingredients (1)

alpelisib (50 mg/1)

Linked Drug Pages (1)

VIJOICE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6993f70f-a922-4520-9537-ec6cea3bd915", "openfda": {"unii": ["08W5N2C97Q"], "rxcui": ["2169310", "2169316", "2169319", "2598459", "2598461", "2598463", "2598464", "2598465", "2598466", "2598467", "2598469", "2598470", "2680135", "2680138", "2680139", "2680140"], "spl_set_id": ["638069a4-aee0-46c9-9e21-54ad449c163c"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "28 PACKET in 1 CARTON (0078-1175-51)  / 1 GRANULE in 1 PACKET (0078-1175-19)", "package_ndc": "0078-1175-51", "marketing_start_date": "20240424"}], "brand_name": "VIJOICE", "product_id": "0078-1175_6993f70f-a922-4520-9537-ec6cea3bd915", "dosage_form": "GRANULE", "product_ndc": "0078-1175", "generic_name": "alpelisib", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VIJOICE", "active_ingredients": [{"name": "ALPELISIB", "strength": "50 mg/1"}], "application_number": "NDA218466", "marketing_category": "NDA", "marketing_start_date": "20240424", "listing_expiration_date": "20261231"}